戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ine SR showed good agreement with myocardial perfusion scintigraphy.
2 cal atherosclerotic disease using myocardial perfusion scintigraphy.
3  pulmonary embolism, supplanting ventilation/perfusion scintigraphy.
4 as a new stress modality in combination with perfusion scintigraphy.
5 ts of greater perfusion defect on myocardial perfusion scintigraphy.
6 n extracted from adenosine stress myocardial perfusion scintigraphy, a commonly performed test, is of
7 or cost-effective applications of myocardial perfusion scintigraphy, a large amount of research has r
8 er, its accuracy in comparison to myocardial perfusion scintigraphy and to that of high dose DE remai
9                                 Conventional perfusion scintigraphy assesses disparities in regional
10 accuracy similar to both CTA and ventilation-perfusion scintigraphy, at lower cost and with lower rad
11                                              Perfusion scintigraphy can provide modest prognostic inf
12                                              Perfusion scintigraphy combined with chest radiography c
13 is diameter 55%+/-11%), underwent myocardial perfusion scintigraphy for documentation of reversible p
14  echocardiography may be more versatile than perfusion scintigraphy for identifying the presence and
15 , semiautomated CT densitometry, and (99m)Tc perfusion scintigraphy in 28 patients being evaluated fo
16  We sought to study the accuracy of exercise perfusion scintigraphy in patients with an implanted api
17                  The specificity of exercise perfusion scintigraphy is decreased in patients with a l
18                          Although myocardial perfusion scintigraphy is of proven value in the risk st
19  risk estimates from 256-slice CTPA and lung perfusion scintigraphy (LPS) for comparison.
20 omprehensive echocardiogram and a myocardial perfusion scintigraphy (MPS) at inclusion.
21 sess the clinical value of stress myocardial perfusion scintigraphy (MPS) in elderly patients (> or =
22 xtent and severity of ischemia on myocardial perfusion scintigraphy (MPS) is commonly used to risk-st
23 ssive and recurring; thus, stress myocardial perfusion scintigraphy (MPS) is widely used to identify
24                                   Myocardial perfusion scintigraphy (MPS) was used to assess adenosin
25              Compared with stress myocardial perfusion scintigraphy (MPS), CCTA was associated with a
26                  Whether abnormal myocardial perfusion scintigraphy (MPS), dobutamine stress echocard
27 rmine appropriateness ratings for myocardial perfusion scintigraphy (MPS), stress echocardiography (S
28 lcium (CAC) scanning and exercise myocardial perfusion scintigraphy (MPS).
29  value for myocardial ischemia on myocardial perfusion scintigraphy of all parameters was compared us
30 o reduction in ischemic burden on myocardial perfusion scintigraphy or in the safety endpoints of maj
31 went lower-extremity ultrasound, ventilation-perfusion scintigraphy, or both, followed by pulmonary C
32 ventional pulmonary angiography, ventilation-perfusion scintigraphy, or lower-extremity ultrasonograp
33 s with left bundle branch block referred for perfusion scintigraphy over a 5-year span.
34                             Gated myocardial perfusion scintigraphy permits simultaneous assessment o
35   Myocardial contractile reserve and resting perfusion scintigraphy provide independent information t
36 onal flow reserve (FFR) compared with stress perfusion scintigraphy (SPS) in patients with recent uns
37 99m)Tc-macroaggregated albumin ((99m)Tc-MAA) perfusion scintigraphy to estimate the liver-to-lung shu
38 ical practice catheter cerebral angiography, perfusion scintigraphy, transcranial Doppler sonography,
39                                              Perfusion scintigraphy using (99m)Tc-labeled albumin agg
40 or rule out CTEPH should include ventilation-perfusion scintigraphy, which has high sensitivity and a
41 tients underwent angiographic assessment and perfusion scintigraphy with (99m)Tc-MAA before lobar (90

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。